TrialPloS one2017

To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).

Vidya Nand Rabi Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.